Press Releases about Merck & Co
Merck Beats Expectations for the Third Quarter as Sales of the COVID-19 Tablet Are Partially Offset by Keytruda
October 27, 2022
Via PressReach
Exposures
COVID-19
Merck Announces Third-Quarter 2022 Financial Results
October 27, 2022
From Merck & Co., Inc.
Via Business Wire
Robert M. Davis to Succeed Kenneth C. Frazier as Chairman of Merck
October 26, 2022
From Merck & Co., Inc.
Via Business Wire
From Merck & Co., Inc.
Via Business Wire
Merck Animal Health Completes Minority Investment in LeeO Precision Farming
September 27, 2022
From Merck & Co., Inc.
Via Business Wire
U.S. District Court Rules In Favor of Merck in Sitagliptin Phosphate Patent Lawsuit
September 22, 2022
Via Business Wire
Merck Foundation Launches $20 Million Initiative to Advance Equity in U.S. Cancer Care
September 08, 2022
From Merck Foundation
Via Business Wire
From Merck & Co., Inc.
Via Business Wire
Monkeypox vaccine and research related stocks taking center stage (VRAX,GOVX,TNXP,APDN)
September 02, 2022
Via AB Newswire
Exposures
COVID-19
Merck Reports Strong Progress in ESG Focus Areas
August 30, 2022
From Merck & Co., Inc.
Via Business Wire
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.